Other Financial Information

9 Months Ended

Sep. 30, 2020

Other Financial Information [Abstract]

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


	September 30, 2020		December 31, 2019
Diagnostic testing supplies	$	841	$	1,427
Prepaid product royalties	72		123
Prepaid maintenance and insurance contracts	897		1,768
Other prepaid and other current assets	14		133
Prepaid and other current assets	$	1,824	$	3,451

Property and Equipment

Property and equipment consist of the following (in thousands):


	September 30, 2020		December 31, 2019
Furniture and fixtures	$	44	$	25
Laboratory equipment	2,663		2,228
Computer equipment and software	927		851
Leasehold improvements	473		424
Construction in progress	438		247
Total property and equipment	4,545		3,775
Less: accumulated depreciation and amortization	(2,787)		(2,395)
Property and equipment, net	$	1,758	$	1,380

Depreciation and amortization expense for the three months ended September 30, 2020 and 2019 was approximately $0.1 million, and for the nine months ended September 30, 2020 and 2019, was approximately $0.4 million and $0.5 million, respectively. At September 30, 2020 and December 31, 2019, the gross book value of assets under capital lease was $1.2 million and $0.8 million, respectively, and is classified in "Laboratory equipment" in the table above.

Accrued and Other Current Liabilities

Accrued and other current liabilities consist of the following (in thousands):


	September 30, 2020		December 31, 2019
Accrued payroll and related expenses	$	3,818	$	2,362

Accrued interest	142		145
Accrued purchases of goods and services	542		319
Accrued royalties	178		727
Accrued clinical study activity	139		40
Capital lease obligations, current portion	272		238
Other accrued liabilities	729		588
Accrued and other current liabilities	$	5,820	$	4,419